Proteinuria is a sign of kidney damage but is also a strong indicator of CKD progression. [3] [4] [5] It was hypothesized that proteinuria accelerates CKD progression by the direct toxic effects of reabsorbed proteins on tubular epithelial cells; 6 this chronic injury induces the release of cytokines, cellular apoptosis, and tubular degeneration and atrophy, that, in turn, leads to interstitial inflammation and fibrosis. 7, 8 Proteinuria in cats with naturally occurring CKD is generally mild, with 90% and 49% of cats with CKD having a urinary protein-to-creatinine (UPC) ratios of <1.0 and <0.25, respectively. 9 The severity of proteinuria, however, has prognostic significance in terms of survival time. 9, 10 Consequently, the American
College of Veterinary Internal Medicine (ACVIM) consensus statement on the treatment of proteinuria recommends therapeutic interventions when the UPC ratio is ≥0.4 in CKD cats with azotemia. 3 Proteinuria can be routinely assessed via semiquantitative methods, such as a urine dipstick colorimetric test. However, false-positive protein reactions in healthy cats and cats with CKD limit its utility. 4, 11, 12 A large amount of cauxin (a 70 kDa glycoprotein) has been demonstrated in feline urine, and it is responsible for false-positive protein results on urine dipstick tests. 13 Therefore, the single best test for the detection of proteinuria in cats is the UPC ratio. 14 The International Interest Renal Society (IRIS) proposed substaging of feline CKD based on UPC ratio and defined nonproteinuric (NP) patients with a UPC ratio ≤0.20, borderline proteinuric (BP) patients with a UPC ratio from 0.21 to 0.40, and proteinuric (P) patients with a UPC ratio >0.40.
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Although the gold standard for detection of proteinuria is the quantification of protein within 24 hours of urine collection, in feline medicine, this approach is impractical. Currently, the quantification of proteinuria with a UPC ratio in spot urine samples is considered a reliable estimation of the daily protein excretion in cats. 16, 17 Although proteinuria in cats is routinely assessed as part of the diagnostic process in patients suspected of CKD, 1, 3, 15 to the authors' knowledge there is no information available about analytical factors that may affect the measurement of proteinuria. Dye-binding methods are easy to use, relatively rapid, and inexpensive, and there are several assays available to quantify urinary proteins. Among these, pyrogallol red-molybdate (PRM) 18, 19 and Coomassie brilliant blue (CBB) 17 are the most used methods. 20, 21 In human medicine, it was shown that different methods for urinary protein quantification yielded discordant results 22, 23 and efforts were made to improve agreement. 24, 25 Similarly, in dogs, the UPC ratio can be affected by different assay principles, and as a consequence, dogs with kidney disease can be incorrectly substaged with the IRIS guidelines. A recent study in dogs showed biases between the CBB and PRM methods for canine urinary protein quantification, and the latter method tended to underestimate protein concentrations. 26 Also, in cats, there are reports demonstrating disagreements between analytical methods different from the PRM and CBB methods. 27, 28 Other factors, such as different preanalytical procedures in different laboratories, storage, or predilution, have been shown to influence the quantification of urinary protein in dogs. 29, 30 It is important to highlight that the IRIS guidelines do not specify which method should be used to assess the thresholds proposed in substaging feline and canine patients with CKD.
No information on the analytical variability of urinary protein quantification in cats is available. Therefore, the aims of this study were to determine whether analytical factors affect UPC ratio assessments in cats. Specifically, the intra-assay and inter-assay repeatability of the UPC ratio measurement were evaluated. In addition, an agreement between the two dye-binding methods (the PRM and CBB methods) for measurement of total protein in feline urine was determined.
| MATERIALS AND METHODS

| Animals and sample collection
Urine samples were prospectively collected from 174 client-owned cats presented for routine diagnostic investigations.
Samples were collected from January 2015 to February 2016 at the Veterinary Teaching Hospital (University of Milan) and a private clinical practice (Veterinary Hospital "Città di Pavia") during routine health screening, under informed consent signed by the owners.
According to the ethical committee statements of the University of Milan (number 2/2016), biological samples collected in this setting could also be used for research purposes.
Due to the analytical nature of this study, cats were enrolled irrespective of age, sex, breed, and underlining disease. Cats with diseases that could affect urine composition (eg, CKD, lower urinary tract inflammation, neoplasia, etc.) were also included.
Eight to 10 mL of urine were collected from each cat by ultrasound-guided cystocentesis. Samples were sent in the syringes to the respective clinical pathology laboratories (labeled as "Lab 1" for University of Milan and "Lab 2" for Ospedale Veterinario "Città di Pavia").
| Urinalysis
Five milliliters of urine were transferred from the syringe to a sterile conical tube and were macroscopically evaluated for physical properties (color and turbidity) and assayed with a dipstick for semiquanti- | 449 preparation and microscopic interpretation were performed according to a previous study. 31 Supernatants designated for "Lab 1"
were used fresh for the analytical procedures described below.
Supernatants collected at "Lab 2" were aliquoted (approximately 2 mL for each sample) and stored at −20°C within 2 hours of collection. Then, aliquots were shipped in batch under a controlled temperature to "Lab 1" for inclusion in the method comparison study (see below).
| Analytical methods
Two commercially available colorimetric test kits were used for protein quantification on the urine supernatants in "Lab 1", one based on the 
| Intra-assay and inter-assay repeatability
The intra-assay imprecision was assessed on 20 fresh urine supernatants, and samples were tested 20 consecutive times in the same run for protein (with both the PRM and CBB methods) and creatinine concentrations, and the UPC ratio was calculated. Mean, SD, and CV (calculated as CV = SD/mean × 100) for UP PRM , UP CBB , and UC were calculated, and then the UPC ratio for each method was calculated first on all of the samples and then on samples with active (n = 11) and inactive sediments (n = 9).
Inter-assay imprecision was assessed on 15 samples, which were immediately aliquoted after sampling, and then, stored at −20°C.
Each sample was measured on five consecutive working days. Urine , UC, and then the UPC ratio was calculated for each method.
| Effect of storage
Since frozen supernatants were used in the method comparison study, a preliminary evaluation of stability at −20°C was performed.
To this aim, 25 fresh urinary supernatants were tested immediately after collection (T 0 ) and after 4 weeks of storage at −20°C (300 μL stored aliquots) for UP PRM and UC after gently thawing and proper mixing before the analyses. These analyses were repeated with an additional 25 samples to test the stability of the UP and UPC ratio measured with the CBB method.
| The method comparison study
Forty samples from "Lab 1" and 80 samples from "Lab 2" were included. Supernatants sent to "Lab 1" were analyzed within 3 hours of collection, while supernatants from "Lab 2" were stored for no longer than 4 weeks at −20°C before the assays were performed.
Urinary protein concentrations were measured using both the PRM and CBB methods, and the UC was measured to allow the calculation of the UPC ratios for each method.
UPC ratios were obtained with both methods (PRM and CBB) and used to classify the patients as NP, BP, or P according to the IRIS staging system. For the influence of different storage conditions on UP, UC, and UPC ratios, results obtained at T 0 and 1 month with both the PRM and CBB methods were compared using a Wilcoxon signed rank test.
| Statistical analysis
For the method comparison study, differences in the UP values obtained with the PRM and CBB methods were compared using the Wilcoxon signed rank test, and correlations were assessed with the Spearman test. The same analysis has been run to compare the UPC ratios calculated using the PRM and the CBB methods. The agreement between the two methods was assessed using the PassingBablok and Bland-Altman tests.
The concordance of the two methods in classifying samples according to IRIS staging of proteinuria was assayed with the Cohen's kappa (k) concordance test. The Cohen's k coefficient was used to define concordance as "very good" (k = 0.8-1), "good"
. 32 Method comparison study tests were performed for all the data and for the samples grouped according to the presence or absence of active sediments. 
| RESULTS
| Intra-assay and inter-assay variability
| Storage
| Method comparison study
Data referred to all samples or samples with inactive or active sediments are reported in Table 3 .
Forty-one (38.7%) urinary samples had active sediments, while 65 (61.3%) had inactive sediments. The most common sediment alteration was hematuria (68.3%), followed by leukocyturia (24.4%), and hematuria and leukocyturia (7.3%).
For the PRM and CBB methods, 66, 17, and 37 samples, and 45, 25, and 50 samples were classified as N, BP, and P, respectively.
The CBB method yielded constantly higher UP and UPC ratios compared with the PRM method, and the difference was significant (P < 0.0001) in all samples.
UP (PRM: P = 0.0146, CBB: P = 0.0104) and the UPC ratio (PRM: P = 0.0035, CBB: P = 0.0087) were significantly different between samples with active and inactive sediments.
Correlations between UP PRM and UP CBB , and between UPC PRM and UPC PRM were highly significant (P < 0.0001) in all sample groups. In the whole sample set, correlation coefficients were 0.82 and 0.91 for the UPs and UPC ratios, respectively. Coefficients in the samples with active sediments were 0.96 for both the UPs and UPC ratios, and in the samples with inactive sediments, coefficients were 0.78 and 0.96 for the UPs and the UPC ratios, respectively.
Statistical results of the method comparison study (including the intercept and slope with 95% confidence intervals) were obtained using Passing-Bablok regression analyses (Figures 1 and 2) , and
Bland-Altman biases with 95% limits of agreement of the UP and the UPC ratio in the whole sample set including samples with active and inactive sediments (Figures 3 and 4) are shown in Table 4 . Constant and proportional errors were found in all sample sets, except for the UPC ratio in inactive sediments that yielded no constant bias.
The agreement in staging samples according to the IRIS guidelines (Table 4 ) was defined as "good" for the whole set of samples (k coefficient =0.62), and "moderate" for both active and inactive sample group (0.59 and 0.56, respectively).
| DISCUSSION
In this study, the analytical quantification variability of feline UPs T A B L E 2 Misclassification frequency of four feline urine samples from the intra-assay study that were tested 20 times and had urine- In this study, frozen urine samples were used for method comparison analyses. Although the UC concentrations were statistically increased after 1 month of storage at −20°C, the lack of statistical differences between the UP concentrations and UPC ratios after 1 month of storage at −20°C suggested that proteinuria measurements could provide reliable results in this setting and confirmed that inclusion of frozen samples had no effect on the method comparison study. It is important to highlight that the impact of storage on feline urinary samples was not an aim of this study. In human medicine, some authors suggested to not use urine samples stored at −20°C for proteinuria quantification, since protein fragmentation (mainly albumin) during storage has been described. 21 However, this could be a major problem when using immunoassays that Similar results were previously reported regarding a smaller number of cats, which compared two different analytical assays (specifically, the colorimetric pyrocatechol violet dye-binding and the turbidimetric benzethonium chloride assays). 27 In our study, the CBB method yielded higher protein concentrations, and in turn, the UPC ratios were increased compared with the PRM method. The CBB method had a similar positive bias in dogs for quantification of urinary 26 and cerebrospinal fluid total proteins. 34 Conversely, in human urine, the CBB method tended to yield lower protein concentrations when compared with PRM. 24 One important cause of the discrepancy between these two methods was shown in the different dye responses to different protein types. For example, both methods showed a constant underestimation of globulin when compared with albumin. 24, [35] [36] [37] Samples included in this study probably presented a large amount of protein variability due to the different underlying diseases, and this variability persisted in the inactive and active samples.
This heterogeneity reflected the actual variability of protein patterns in samples commonly assayed in diagnostic laboratories and allowed analytical variability quantification from a practical standpoint. Urine protein content analysis was beyond the aims of this study, and determination regarding agreements between the different methods or protein patterns during specific diseases needs further research.
Using the same calibration standard for the different methods and using mixed proteins instead of single proteins (such as albumin)
as standard solutions were shown to improve the agreement between methods since the response of proteins to different dyes can be variable. 24 The two methods evaluated in this study were calibrated with the standards provided by the manufacturers. The use of the original standards had the aim to assess the actual variability that could occur between laboratories. Further studies are needed to evaluate whether the agreement between the PRM and CBB methods improves using the same standards, possibly composed of mixed proteins or feline urinary proteins.
T A B L E 4
The intercept and slope of Passing-Bablok tests, and biases and P-values recorded in Bland-Altman tests (shown in Figure 2 and 3 The concordance in classifying samples according to IRIS substaging never reached the higher classification category according to Cohen's k coefficients (ie, "very good"). Although concordance in active and inactive samples was "moderate" and lower than that found in all samples, the k coefficients were very close in magnitude and concordance among the three different sample sets and could be considered similar. These low concordances were due to misclassification of samples when using the CBB method in the higher IRIS stages, as discussed above. In this regard, it is worth noting that in some cases the magnitude of bias was so high that samples were graded as nonproteinuric with the PRM method and proteinuric with the CBB method. These patients would thus experience different diagnostic approaches and possibly different therapies. Taken together, the results of this method comparison study showed that using the same laboratory and methods should be recommended when monitoring patients over time and that the comparison of results between different laboratories should be avoided. Moreover, using external reference intervals (as defined by IRIS) could exacerbate the clinical effects of analytical variability. Therefore, according to these results, using laboratory specific reference intervals, as suggested in human medicine, 23 the modification of IRIS cutoffs relative to the different methods 38 or to one standard method defined by IRIS should be advocated.
In conclusion, both the PRM and CBB methods were precise but 
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